Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea

David M. Kendall; Matthew C. Riddle; Julio Rosenstock; Dongliang Zhuang; Dennis D. Kim; Mark S. Fineman; Alain D. Baron

doi:10.2337/diacare.28.5.1083

Emerging Treatments and Technologies

Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea

David M. Kendall, MD1,
Matthew C. Riddle, MD2,
Julio Rosenstock, MD3,
Dongliang Zhuang, PHD4,
Dennis D. Kim, MD4,
Mark S. Fineman, BS4 and
Alain D. Baron, MD4

¹International Diabetes Center and University of Minnesota, Minneapolis, Minnesota
²Section of Diabetes, Oregon Health & Science University, Portland, Oregon
³Dallas Diabetes and Endocrine Center, Dallas, Texas
⁴Amylin Pharmaceuticals, San Diego, California

Address correspondence and reprint requests to Alain D. Baron, MD, Senior Vice President, Research, Amylin Pharmaceuticals, 9360 Towne Centre Dr., Suite 110, San Diego, CA 92121. E-mail: abaron{at}amylin.com

Diabetes Care 2005 May; 28(5): 1083-1091. https://doi.org/10.2337/diacare.28.5.1083

Article Information

vol. 28 no. 5 1083-1091

DOI

https://doi.org/10.2337/diacare.28.5.1083

PubMed

15855571

Published By

American Diabetes Association

Print ISSN

0149-5992

Online ISSN

1935-5548

History

January 31, 2005
September 27, 2004
Published in print May 1, 2005.
Published online April 26, 2005.

DIABETES CARE

Author Information

David M. Kendall, MD1,
Matthew C. Riddle, MD2,
Julio Rosenstock, MD3,
Dongliang Zhuang, PHD4,
Dennis D. Kim, MD4,
Mark S. Fineman, BS4 and
Alain D. Baron, MD4

¹International Diabetes Center and University of Minnesota, Minneapolis, Minnesota
²Section of Diabetes, Oregon Health & Science University, Portland, Oregon
³Dallas Diabetes and Endocrine Center, Dallas, Texas
⁴Amylin Pharmaceuticals, San Diego, California

Address correspondence and reprint requests to Alain D. Baron, MD, Senior Vice President, Research, Amylin Pharmaceuticals, 9360 Towne Centre Dr., Suite 110, San Diego, CA 92121. E-mail: abaron{at}amylin.com

View Full Text

Statistics from Altmetric.com

Article usage

Article usage: April 2005 to July 2019

Rendering graph...

	Abstract	Full	Pdf
Apr 2005	227	192	227
May 2005	645	1082	637
Jun 2005	220	740	269
Jul 2005	193	569	303
Aug 2005	119	717	305
Sep 2005	167	723	236
Oct 2005	189	720	207
Nov 2005	130	469	439
Dec 2005	64	271	245
Jan 2006	76	327	281
Feb 2006	100	389	304
Mar 2006	64	368	317
Apr 2006	69	286	204
May 2006	66	208	165
Jun 2006	83	235	235
Jul 2006	93	256	205
Aug 2006	72	217	217
Sep 2006	59	289	237
Oct 2006	61	325	272
Nov 2006	79	276	219
Dec 2006	43	165	143
Jan 2007	68	248	248
Feb 2007	53	214	199
Mar 2007	87	245	234
Apr 2007	71	204	176
May 2007	39	166	170
Jun 2007	34	115	145
Jul 2007	41	142	157
Aug 2007	31	123	137
Sep 2007	47	133	154
Oct 2007	70	184	200
Nov 2007	87	175	172
Dec 2007	79	118	134
Jan 2008	169	182	214
Feb 2008	132	166	185
Mar 2008	171	194	190
Apr 2008	131	165	162
May 2008	100	162	157
Jun 2008	85	142	148
Jul 2008	82	120	127
Aug 2008	67	134	149
Sep 2008	73	133	159
Oct 2008	67	151	172
Nov 2008	64	127	115
Dec 2008	47	92	131
Jan 2009	31	100	98
Feb 2009	40	102	114
Mar 2009	42	97	139
Apr 2009	42	167	149
May 2009	22	58	62
Jun 2009	108	51	71
Jul 2009	189	88	81
Aug 2009	118	66	70
Sep 2009	267	105	85
Oct 2009	241	132	93
Nov 2009	123	142	84
Dec 2009	134	136	76
Jan 2010	140	171	104
Feb 2010	149	202	125
Mar 2010	167	187	108
Apr 2010	117	221	100
May 2010	121	133	56
Jun 2010	157	122	83
Jul 2010	85	139	75
Aug 2010	113	168	98
Sep 2010	114	171	84
Oct 2010	116	192	102
Nov 2010	92	204	90
Dec 2010	76	172	84
Jan 2011	118	153	91
Feb 2011	113	148	78
Mar 2011	191	138	105
Apr 2011	203	92	105
May 2011	182	104	108
Jun 2011	162	76	81
Jul 2011	180	93	83
Aug 2011	183	105	94
Sep 2011	207	135	110
Oct 2011	210	107	99
Nov 2011	199	111	79
Dec 2011	146	88	71
Jan 2012	187	66	69
Feb 2012	126	68	70
Mar 2012	235	76	97
Apr 2012	218	104	78
May 2012	204	81	86
Jun 2012	147	70	58
Jul 2012	179	66	52
Aug 2012	200	74	82
Sep 2012	188	72	70
Oct 2012	204	89	79
Nov 2012	216	97	63
Dec 2012	168	66	68
Jan 2013	217	114	92
Feb 2013	220	104	82
Mar 2013	270	101	89
Apr 2013	233	102	93
May 2013	221	90	233
Jun 2013	150	52	65
Jul 2013	146	138	68
Aug 2013	117	116	60
Sep 2013	142	153	65
Oct 2013	146	155	59
Nov 2013	169	204	59
Dec 2013	128	129	55
Jan 2014	156	151	45
Feb 2014	99	81	44
Mar 2014	190	114	83
Apr 2014	125	82	72
May 2014	103	68	61
Jun 2014	94	64	43
Jul 2014	165	97	56
Aug 2014	85	61	43
Sep 2014	99	61	50
Oct 2014	116	75	56
Nov 2014	115	50	64
Dec 2014	108	50	40
Jan 2015	114	131	47
Feb 2015	105	194	30
Mar 2015	202	185	82
Apr 2015	139	114	69
May 2015	134	109	51
Jun 2015	108	90	56
Jul 2015	100	56	63
Aug 2015	114	107	54
Sep 2015	140	42	33
Oct 2015	140	42	39
Nov 2015	127	45	41
Dec 2015	149	65	38
Jan 2016	135	56	47
Feb 2016	132	41	29
Mar 2016	164	85	73
Apr 2016	171	55	41
May 2016	120	187	53
Jun 2016	69	102	40
Jul 2016	78	93	49
Aug 2016	97	119	55
Sep 2016	69	123	55
Oct 2016	94	108	37
Nov 2016	92	84	37
Dec 2016	66	91	31
Jan 2017	69	168	65
Feb 2017	84	106	37
Mar 2017	93	116	37
Apr 2017	88	87	40
May 2017	66	141	56
Jun 2017	52	90	34
Jul 2017	33	121	28
Aug 2017	53	78	32
Sep 2017	45	106	28
Oct 2017	43	115	16
Nov 2017	59	113	29
Dec 2017	36	77	25
Jan 2018	53	80	26
Feb 2018	69	105	30
Mar 2018	49	72	30
Apr 2018	43	79	26
May 2018	27	84	37
Jun 2018	26	64	12
Jul 2018	22	64	42
Aug 2018	30	64	26
Sep 2018	36	93	23
Oct 2018	42	77	27
Nov 2018	50	93	33
Dec 2018	37	62	28
Jan 2019	25	51	21
Feb 2019	20	52	27
Mar 2019	22	52	35
Apr 2019	16	69	36
May 2019	26	102	33
Jun 2019	19	64	28
Jul 2019	8	30	30